A
Adverum Biotechnologies (ADVM)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Adverum Biotechnologies (ADVM)
Adverum Biotechnologies, Inc. operates as a biotechnology company. The Company focuses on targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitrea... Read more
- USD3.16
- USD3.30
- USD2.77
- USD10.14
- -21.50%
- 1M
- 354.10k
- 540.44k
- 73M
- 2.64
- -70.80%
Stock News
4 hours ago
FAA weighs reducing Newark flights after hundreds of disruptions
CNBC
5 hours ago
Lutnick says 10% baseline tariff will stick around for "foreseeable future"
CNBC
6 hours ago
The ‘most important consumer earnings report of the season’ lands this week
MarketWatch
6 hours ago
People are feeling lousy about work. The internet's career advice expert has some tips
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
